Registry of Toxic Effects of Chemical Substances (RTECS)
Toluene, alpha-chloro-
RTECS #
XS8925000CAS #
100-44-7Updated
September 201Molecular Weight
126.59Molecular Formula
C7H7ClSynonyms
alpha-Chlorotoluenealpha-Chlortoluol (German)
Benzene, (chloromethyl)-
Benzile (cloruro di) (Italian)
Benzyl chloride
Benzyl chloride (ACGIH:OSHA)
Benzylchlorid (German)
Benzyle (chlorure de) (French)
Chloromethylbenzene
Chlorophenylmethane
Chlorure de benzyle (French)
NCI-C06360
omega-Chlorotoluene
RCRA waste number P028
Tolyl chloride
Mutation Data and Reference
System Test | Route/Organism/Tissue | Dose | Reference |
---|---|---|---|
Cytogenetic Analysis | other cell types/rat | 120 µmol/L | PMRSDJ 4,247,1982 |
DNA Damage | lymphocyte/mouse | 393 µmol/L | MUREAV 203,155,1988 |
DNA Damage | fibroblast/human | 1 mmol/L | MUREAV 145,209,1985 |
DNA Damage | other cell types/human | 1 mmol/L | MUREAV 145,209,1985 |
DNA repair | /Escherichia coli | 10 mg/L | JJIND8 62,873,1979 |
DNA repair | /Bacillus subtilis | 79200 nmol/disc | MUREAV 58,143,1978 |
gene conversion and mitotic recombination | /Saccharomyes cerevisiae | 400 ppm | JJIND8 62,901,1979 |
micronucleus test | embryo/hamster | 1 µmol/L | MUREAV 203,397,1988 |
micronucleus test | lung/hamster | 313 µmol/L/6H (-enzymatic activation step) | MUTAEX 26,709,2011 |
micronucleus test | lung/hamster | 1250 µmol/L/6H (+enzymatic activation step) | MUTAEX 26,709,2011 |
micronucleus test | lung/hamster | 625 µmol/L/48H (-enzymatic activation step) | MUTAEX 26,709,2011 |
morphological transform | embryo/hamster | 1600 µg/L | CRNGDP 1,323,1980 |
mutation in mammalian somatic cells | lymphocyte/mouse | 8 mg/L | EMMUEG 11,91,1988 |
mutation in microorganisms | /Salmonella typhimurium | 7900 nmol/plate (+enzymatic activation step) | MUREAV 58,143,1978 |
mutation in microorganisms | /Salmonella typhimurium | 666 µg/plate (-enzymatic activation step) | ENMUDM 9(Suppl 9),1,1987 |
mutation in microorganisms | /Escherichia coli | 6300 nmol/plate (-enzymatic activation step) | MUREAV 58,143,1978 |
mutation in microorganisms | /Salmonella typhimurium | 28 mg/L/2H (-enzymatic activation step) | MUREAV 578,210,2005 |
mutation in microorganisms | /Salmonella typhimurium | 50 mg/L/2H (+enzymatic activation step) | MUREAV 578,210,2005 |
mutation in microorganisms | /Salmonella typhimurium | 500 µg/plate/48H (-enzymatic activation step) | MUREAV 633,13,2007 |
mutation in microorganisms | /Salmonella typhimurium | 200 µg/plate/48H (+enzymatic activation step) | MUREAV 633,13,2007 |
mutation in microorganisms | /Salmonella typhimurium | 250 µg/plate (+/-enzymatic activation step) | MUREAV 633,13,2007 |
mutation in microorganisms | /Salmonella typhimurium | 1000 µg/plate/3H (+/-enzymatic activation step) | MUREAV 633,13,2007 |
mutation in microorganisms | /Salmonella typhimurium | 500 µg/plate/48H (+/-enzymatic activation step) | MUREAV 633,13,2007 |
sister chromatid exchange | ovary/hamster | 100 µmol/L | JJATDK 3,203,1983 |
Unscheduled DNA Synthesis | HeLa cell/human | 50 µmol/L | CALEDQ 20,263,1983 |
Reproductive Effects Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
intraperitoneal/mouse | 250 mg/kg (5D male) | Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | MUREAV 100,345,1982 |
oral/rat | 1 gm/kg (6-15D pregnant) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) | JTEHD6 17,51,1986 |
oral/rat | 11 µg/kg (1-19D pregnant) | Reproductive: Effects on embryo or fetus: Fetal death | GISAAA 44(3),11,1979 |
oral/rat | 1000 mg/kg (6-15D pregnant) | Reproductive: Effects on embryo or fetus: Fetotoxicity (except death, e.g., stunted fetus) Reproductive: Other developmental abnormalities | VCVGK* -,40,1994 |
subcutaneous/mouse | 2500 mg/kg (5D male) | Reproductive: Paternal effects: Spermatogenesis (including genetic material, sperm morphology, motility, and count) | MUREAV 100,345,1982 |
Tumorigenic Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
oral/mouse | lowest published toxic dose: 31 gm/kg/2Y- intermittent | Tumorigenic: Carcinogenic by RTECS criteria Vascular: Tumors Gastrointestinal: Tumors | JJIND8 76,1231,1986 |
skin/mouse | lowest published toxic dose: 9200 mg/kg/50W- intermittent | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Lung, Thorax, or Respiration: Tumors Skin and Appendages: Tumors | GANNA2 72,655,1981 |
subcutaneous/rat | toxic dose: 2100 mg/kg/53W- intermittent | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Tumorigenic: Tumors at site of application | ZEKBAI 74,241,1970 |
subcutaneous/rat | lowest published toxic dose: 50 mg/kg | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Tumorigenic: Tumors at site of application | FCTXAV 6,576,1968 |
Acute Toxicity Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/cat | Lowest published lethal concentration: 400 ppm/8H | Eye: Corneal damage Lung, Thorax, or Respiration: Acute pulmonary edema Lung, Thorax, or Respiration: Cough | NTIS** OTS0572390 |
inhalation/cat | lowest published toxic concentration: 200 mg/m3/8H | Lung, Thorax, or Respiration: Cough | VCVGK* -,40,1984 |
inhalation/cat | Lowest published lethal concentration: 2000 mg/m3 | Lung, Thorax, or Respiration: Acute pulmonary edema Lung, Thorax, or Respiration: Other changes | VCVGK* -,40,1984 |
inhalation/human | lowest published toxic concentration: 160 mg/m3 | Olfaction: Other olfaction effects Eye: Lacrimation Eye: Conjunctiva irritation | VCVGK* -,40,1984 |
inhalation/human | lowest published toxic concentration: 40 mg/m3/10S | Eye: Lacrimation Eye: Conjunctiva irritation | VCVGK* -,40,1984 |
inhalation/human | lowest published toxic concentration: 500 mg/m3 | Olfaction: Other olfaction effects | VCVGK* -,40,1984 |
inhalation/mammal (species unspecified) | lethal concentration (50 percent kill): 390 mg/m3 | GTPZAB 30(3),6,1986 | |
inhalation/mouse | lethal concentration (50 percent kill): 390 mg/m3/2H | VCVGK* -,39,1984 | |
inhalation/mouse | lethal concentration (50 percent kill): 80 ppm/2H | Lung, Thorax, or Respiration: Respiratory depression | IMEMDT 11,217,1976 |
inhalation/mouse | lowest published toxic concentration: 5 ppm/6M | Lung, Thorax, or Respiration: Respiratory depression | TOLED5 9,137,1981 |
inhalation/mouse | lethal concentration (50 percent kill): 0.39 gm/m3 | TPKVAL 9,27,1967 | |
inhalation/rat | lethal concentration (50 percent kill): 0.74 gm/m3 | TPKVAL 9,27,1967 | |
inhalation/rat | lethal concentration (50 percent kill): 150 ppm/2H | Lung, Thorax, or Respiration: Respiratory depression | IMEMDT 11,217,1976 |
inhalation/rat | lethal concentration (50 percent kill): 740 mg/m3/2H | VCVGK* -,39,1984 | |
intravenous/rat | lowest published toxic dose: 25 mg/kg | Liver: Other changes | VCVGK* -,39,1984 |
oral/mammal (species unspecified) | lethal dose (50 percent kill): 1500 mg/kg | GISAAA 40(1),92,1975 | |
oral/mouse | lethal dose (50 percent kill): 1500 mg/kg | 85GMAT -,25,1982 | |
oral/rat | lethal dose (50 percent kill): 1231 mg/kg | NTIS** PB214-270 | |
oral/rat | lowest published toxic dose: 100 mg/kg | Liver: Other changes Blood: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Other transferases | AECTCV 18,670,1989 |
skin/guinea pig | lowest published lethal dose: 10 mL/kg | NTIS** OTS0572390 | |
subcutaneous/rat | lethal dose (50 percent kill): 1 gm/kg | ZEKBAI 74,241,1970 | |
unreported route/mouse | lethal dose (50 percent kill): 780 mg/kg | GISAAA 44(3),11,1979 | |
unreported route/rat | lethal dose (50 percent kill): 625 mg/kg | GISAAA 44(3),11,1979 |
Other Multiple Dose Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
inhalation/cat | lowest published toxic concentration: 480 mg/m3/6D- intermittent | Lung, Thorax, or Respiration: Other changes Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | VCVGK* -,40,1994 |
inhalation/mouse | lowest published toxic concentration: 46 ppm/6H/14D- intermittent | Olfaction: Other olfaction effects | JJATDK 15,207,1995 |
inhalation/rabbit | lowest published toxic concentration: 480 mg/m3/6D- intermittent | Olfaction: Other olfaction effects | VCVGK* -,40,1994 |
oral/mouse | lowest published toxic dose: 7800 mg/kg/26W- intermittent | Liver: Other changes | JJIND8 76,1231,1986 |
oral/rat | lowest published toxic dose: 4836 mg/kg/26W- intermittent | Cardiac: Other changes Gastrointestinal: Necrotic changes Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | JJIND8 76,1231,1986 |
oral/rat | lowest published toxic dose: 500 mg/kg/8D- intermittent | Gastrointestinal: Ulceration or bleeding from stomach Related to Chronic Data: Death in the "MULTIPLE DOSE" data type field | JTEHD6 10,837,1982 |
Reviews
Organization | Standard | Reference |
---|---|---|
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-time-weighted average 1 ppm | DTLVS* TLV/BEI,2013 |
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-Confirmed animal carcinogen | DTLVS* TLV/BEI,2013 |
International Agency for Research on Cancer (IARC) | Cancer Review:Animal Limited Evidence | IMEMDT 29,49,1982 |
International Agency for Research on Cancer (IARC) | Cancer Review:Animal Sufficient Evidence | IMEMDT 71,453,1999 |
International Agency for Research on Cancer (IARC) | Cancer Review:Human Limited Evidence | IMEMDT 71,453,1999 |
International Agency for Research on Cancer (IARC) | Cancer Review:Human Inadequate Evidence | IMEMDT 29,49,1982 |
TOXICOLOGY REVIEW | MUREAV 567,347,2004 | |
TOXICOLOGY REVIEW | MUREAV 626,135,2007 | |
TOXICOLOGY REVIEW | MUREAV 584,1,2005 | |
TOXICOLOGY REVIEW | MUREAV 654,114,2008 | |
TOXICOLOGY REVIEW | MUREAV 672,10,2009 | |
TOXICOLOGY REVIEW | MUREAV 672,17,2009 | |
TOXICOLOGY REVIEW | MUTAEX 23,271,2008 |
Standards and Regulations
Organization | Standard | Reference |
---|---|---|
Mine Safety and Health Administration (MSHA) STANDARD-air | time-weighted average 1 ppm (5 mg/m3) | DTLVS* 3,24,1971 |
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN check ACGIH TLV; | ||
Occupational Exposure Limit IN SINGAPORE, VIETNAM check ACGIH TLV | ||
Occupational Exposure Limit-AUSTRALIA | time-weighted average 1 ppm (5.2 mg/m3), JUL2008 | |
Occupational Exposure Limit-AUSTRIA | TRK-TMW 0.2 mg/m3;KZW 0.8 mg/m3, 2007 | |
Occupational Exposure Limit-BELGIUM | time-weighted average 1 ppm (5.3 mg/m3), MAR2002 | |
Occupational Exposure Limit-DENMARK | ceiling concentration 1 ppm (5 mg/m3), carc, MAY2011 | |
Occupational Exposure Limit-FINLAND | time-weighted average 0.5 ppm (2.6 mg/m3), ceiling concentration 1.5 ppm (7.9 mg/m3), NOV2011 | |
Occupational Exposure Limit-FRANCE | VME 1 ppm (5 mg/m3), short term exposure limit 2 ppm (11 mg/m3), C2 Carcinogen, FEB2006 | |
Occupational Exposure Limit-HUNGARY | time-weighted average 0.5 mg/m3, short term exposure limit 0.5 mg/m3, Skin, SEP2000 | |
Occupational Exposure Limit-ICELAND | short term exposure limit 1 ppm (5 mg/m3), carc, NOV2011 | |
Occupational Exposure Limit-JAPAN | 2A carc, MAY2012 | |
Occupational Exposure Limit-KOREA | time-weighted average 1 ppm (5 mg/m3), 2006 | |
Occupational Exposure Limit-MEXICO | time-weighted average 1 ppm (5 mg/m3), 2004 | |
Occupational Exposure Limit-NEW ZEALAND | time-weighted average 1 ppm (5.2 mg/m3), JAN2002 | |
Occupational Exposure Limit-NORWAY | time-weighted average 1 ppm (5 mg/m3), JAN1999 | |
Occupational Exposure Limit-PERU | time-weighted average 1 ppm (5.2 mg/m3), JUL2005 | |
Occupational Exposure Limit-POLAND | time-weighted average 3 mg/m3, CEILING 5 mg/m3, JAN1999 | |
Occupational Exposure Limit-RUSSIA | short term exposure limit 0.5 mg/m3, JUN2003 | |
Occupational Exposure Limit-SWEDEN | time-weighted average 1 ppm (5 mg/m3);short term exposure limit 2 ppm (11 mg/m3), Carcinogen, JUN2005 | |
Occupational Exposure Limit-SWITZERLAND | MAK-week 0.2 mg/m3, carc 2, skin, JAN2011 | |
Occupational Exposure Limit-SWITZERLAND | carc 1, JAN2011 | |
Occupational Exposure Limit-THE PHILIPPINES | time-weighted average 1 ppm (5 mg/m3), JAN1993 | |
Occupational Exposure Limit-TURKEY | time-weighted average 1 ppm (5 mg/m3), JAN1993 | |
Occupational Exposure Limit-UNITED KINGDOM | time-weighted average 0.5 ppm (2.6 mg/m3);short term exposure limit 1.5 ppm (7.9 mg/m3), carc, OCT2007 | |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction) | 8H time-weighted average 1 ppm (5 mg/m3) | CFRGBR 29,1926.55,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Federal Contractors) | 8H time-weighted average 1 ppm (5 mg/m3) | CFRGBR 41,50-204.50,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (General Industry) | 8H time-weighted average 1 ppm (5 mg/m3) | CFRGBR 29,1910.1000,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards) | 8H time-weighted average 1 ppm (5 mg/m3) | CFRGBR 29,1915.1000,1993 |
NIOSH Documentation and Surveillance
Organization | Standard | Reference |
---|---|---|
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO BENZYL CHLORIDE-air | ceiling concentration 1 ppm/15M | NIOSH* DHHS #92-100,1992 |
National Occupational Exposure Survey 1983 | Hazard Code 11600; Number of Industries 29; Total Number of Facilities 1877; Number of Occupations 25; Total Number of Employees Exposed 41075; Total Number of Female Employees Exposed 8440 | |
National Occupational Hazard Survey 1974 | Hazard Code 11600; Number of Industries 5; Total Number of Facilities 172; Number of Occupations 10; Total Number of Employees Exposed 30504 |
Status in Federal Agencies
Organization | Reference |
---|---|
EPA GENETOX PROGRAM 1988, Inconclusive: CHO gene mutation | |
EPA GENETOX PROGRAM 1988, Negative: Host-mediated assay | |
EPA GENETOX PROGRAM 1988, Positive/limited: Carcinogenicity-mouse/rat | |
EPA GENETOX PROGRAM 1988, Positive: E coli polA without S9; E coli polA with S9 | |
EPA GENETOX PROGRAM 1988, Positive: Histidine reversion-Ames test | |
EPA GENETOX PROGRAM 1988, Positive: In vitro UDS-human fibroblast; S cerevisiae-homozygosis | |
EPA GENETOX PROGRAM 1988, Positive: SHE-clonal assay; B subtilis rec assay | |
EPA TSCA 8(a) PRELIMINARY ASSESSMENT INFORMATION, FINAL RULE | FEREAC 47,26992,82 |
EPA TSCA Section 8(b) CHEMICAL INVENTORY | |
EPA TSCA Section 8(d) unpublished health/safety studies | |
EPA TSCA Section 8(e) Risk Notification, 8EHQ-0892-9001;8EHQ-0892-8910 | |
EPA TSCA TEST SUBMISSION (TSCATS) DATA BASE, JANUARY 2001 | |
NCI Carcinogenesis Studies (feed);clear evidence:mouse | JJIND8 76,1231,1986 |
NCI Carcinogenesis Studies (feed);inadequate:rat | JJIND8 76,1231,1986 |
NIOSH Analytical Method, 1994: Hydrocarbons, halogenated, 1003 | |
On EPA IRIS database |
- Page last reviewed:March 7, 2014
- Page last updated:February 6, 2017
- Content source:
- National Institute for Occupational Safety and Health (NIOSH) Education and Information Division